$11.65
3.40% today
Nasdaq, Aug 25, 06:47 pm CET
ISIN
US15678C1027
Symbol
CBLL

Ceribell Stock price

$12.06
-3.46 22.29% 1M
-13.37 52.58% 6M
-13.82 53.40% YTD
-4.94 29.06% 1Y
-4.94 29.06% 3Y
-4.94 29.06% 5Y
-4.94 29.06% 10Y
-4.94 29.06% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.38 3.25%
ISIN
US15678C1027
Symbol
CBLL

Key metrics

Basic
Market capitalization
$442.2m
Enterprise Value
$284.4m
Net debt
positive
Cash
$177.4m
Shares outstanding
36.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.7 | 5.0
EV/Sales
3.7 | 3.2
EV/FCF
negative
P/B
2.6
Financial Health
Equity Ratio
84.8%
Return on Equity
-21.2%
ROCE
-27.0%
ROIC
-193.8%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$77.4m | $88.4m
EBITDA
$-50.7m | $-54.3m
EBIT
$-52.0m | $-59.4m
Net Income
$-49.4m | $-57.9m
Free Cash Flow
$-38.3m
Growth (TTM | estimate)
Revenue
- | 35.1%
EBITDA
- | -40.7%
EBIT
- | -49.5%
Net Income
- | -43.2%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
87.8%
EBITDA
-65.5% | -61.4%
EBIT
-67.1%
Net
-63.8% | -65.6%
Free Cash Flow
-49.4%
More
EPS
$-1.4
FCF per Share
$-1.0
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Ceribell a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Ceribell Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Ceribell forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Ceribell forecast:

Buy
92%
Hold
8%

Financial data from Ceribell

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
77 77
-
100%
- Direct Costs 9.48 9.48
-
12%
68 68
-
88%
- Selling and Administrative Expenses 104 104
-
134%
- Research and Development Expense 16 16
-
21%
-51 -51
-
-65%
- Depreciation and Amortization 1.27 1.27
-
2%
EBIT (Operating Income) EBIT -52 -52
-
-67%
Net Profit -49 -49
-
-64%

In millions USD.

Don't miss a Thing! We will send you all news about Ceribell directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Ceribell Stock News

Positive
The Motley Fool
19 days ago
CeriBell (CBLL) Q2 Revenue Jumps 38%
Neutral
Seeking Alpha
20 days ago
CeriBell, Inc. (NASDAQ:CBLL ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Scott Blumberg - Chief Financial Officer Xingjuan Chao - Co-Founder, President, CEO & Director Conference Call Participants Brandon Vazquez - William Blair & Company L.L.C., Research Division Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division Joshua Thomas Jennings -...
Neutral
GlobeNewsWire
20 days ago
SUNNYVALE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended June 30, 2025.
More Ceribell News

Company Profile

Ceribell, Inc. is a commercial-stage medical technology company, which focuses on transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Xing Chao
Website ceribell.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today